343 related articles for article (PubMed ID: 10469960)
1. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
[TBL] [Abstract][Full Text] [Related]
2. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation.
Rinder CS; Smith MJ; Rinder HM; Cortright DN; Brodbeck RM; Krause JE; Smith BR
Ann Thorac Surg; 2007 Jan; 83(1):146-52. PubMed ID: 17184649
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses.
Rinder C; Fitch J
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S6-12. PubMed ID: 8938278
[TBL] [Abstract][Full Text] [Related]
5. Role of C3 cleavage in monocyte activation during extracorporeal circulation.
Rinder CS; Rinder HM; Johnson K; Smith M; Lee DL; Tracey J; Polack G; Higgins P; Yeh CG; Smith BR
Circulation; 1999 Aug; 100(5):553-8. PubMed ID: 10430771
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits.
Fung M; Loubser PG; Undar A; Mueller M; Sun C; Sun WN; Vaughn WK; Fraser CD
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):113-22. PubMed ID: 11436043
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
[TBL] [Abstract][Full Text] [Related]
9. Nafamostat preserves neutrophil deformability and reduces microaggregate formation during simulated extracorporeal circulation.
Hiramatsu Y; Homma S; Sato Y; Sato S; Matsuzaki K; Shigeta O; Sakakibara Y
Ann Thorac Surg; 2005 Apr; 79(4):1326-32. PubMed ID: 15797071
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
[TBL] [Abstract][Full Text] [Related]
11. ONO-6818, a novel, potent neutrophil elastase inhibitor, reduces inflammatory mediators during simulated extracorporeal circulation.
Yoshimura Y; Hiramatsu Y; Sato Y; Homma S; Enomoto Y; Jikuya T; Sakakibara Y
Ann Thorac Surg; 2003 Oct; 76(4):1234-9. PubMed ID: 14530017
[TBL] [Abstract][Full Text] [Related]
12. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
Straub A; Wendel HP; Azevedo R; Ziemer G
Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
[TBL] [Abstract][Full Text] [Related]
13. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation.
Sundaram S; Gikakis N; Hack CE; Niewiarowski S; Edmunds LH; Koneti Rao A; Sun L; Cooper SL; Colman RW
Thromb Haemost; 1996 Jan; 75(1):76-82. PubMed ID: 8713783
[TBL] [Abstract][Full Text] [Related]
14. Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation.
Wachtfogel YT; Kettner C; Hack CE; Nuijens JH; Reilly TM; Knabb RM; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
Thromb Haemost; 1998 Oct; 80(4):686-91. PubMed ID: 9798991
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin reduces monocyte and neutrophil CD11b up regulation in addition to blocking platelet activation during extracorporeal circulation.
Rinder CS; Rinder HM; Smith MJ; Fitch JC; Tracey JB; Chandler WL; Rollins SA; Smith BR
Transfusion; 2006 Jul; 46(7):1130-7. PubMed ID: 16836559
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
17. Time sequence of blood activation by nanoporous alumina: Studies on platelets and complement system.
Ferraz N; Ott MK; Hong J
Microsc Res Tech; 2010 Dec; 73(12):1101-9. PubMed ID: 20232464
[TBL] [Abstract][Full Text] [Related]
18. The volatile anesthetic sevoflurane inhibits activation of neutrophil granulocytes during simulated extracorporeal circulation.
Schmid E; Krajewski S; Bachmann D; Kurz J; Wendel HP; Rosenberger P; Balkau B; Peter K; Unertl K; Straub A
Int Immunopharmacol; 2012 Oct; 14(2):202-8. PubMed ID: 22824074
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival.
Davis EA; Lam TT; Qian Z; Ibrahim S; Baldwin WM; Sanfilippo FP
J Heart Lung Transplant; 1995; 14(5):973-80. PubMed ID: 8800736
[TBL] [Abstract][Full Text] [Related]
20. Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets.
Martel C; Cointe S; Maurice P; Matar S; Ghitescu M; Théroux P; Bonnefoy A
PLoS One; 2011 Apr; 6(4):e18812. PubMed ID: 21526204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]